MOLLY ROLEN: Open Payments
NPI 1811659394 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 29 payments from 14 companies in 2025. Trend: 2023 $245 · 2024 $507 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $107 |
| Otsuka America Pharmaceutical, Inc. | 3 | $79 |
| ABBVIE INC. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| SANOFI-AVENTIS U.S. LLC | 2 | $43 |
| ViiV Healthcare Company | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Lilly USA, LLC | 2 | $33 |
| ACADIA Pharmaceuticals Inc | 1 | $25 |
Products named: REXULTI, Ozempic, TZIELD, Wegovy, AIRSUPRA, QULIPTA, CAPLYTA, MOUNJARO.
Industry payments across TN — which companies pay providers there.
